Abstract
Difficulties in the treatment of COVID-19 have determined the need to systematize the factors for the development of complications, critical conditions and death. Endocrine and metabolic disorders associated with obesity, insulin resistance, chronic inflammation, and lipid and fatty acid metabolism disorders increase immunological dysregulation and make these patients vulnerable to infection. The data from the observations made it possible to single out diabetes mellitus, obesity as a risk factor aggravating the course of COVID-19, and to state the duration of the virus elimination period, potentiation of cardiovascular diseases, an increase in the production of pro-inflammatory cytokines, coagulopathy - factors in the development of unfavorable outcomes. The article presents generalized data on the organization of medical care for patients with endocrine pathology during the coronavirus pandemic
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Public health of the Far East Peer-reviewed scientific and practical journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
